CHRW monthly performance report
Monthly CHRW research: returns, drawdown, relative strength, seasonality, and key stats.
CHRW monthly report
—
Key takeaways
- C.H. Robinson (CHRW) closed September 2026 at $152.42, up 1.84% for the month and +19.41% over the trailing 12 months.
- Year-to-date, CHRW is −5.19%, underperforming the S&P 500 which has returned +11.13% YTD.
- The stock is trading −11.70% versus its 200-day moving average ($172.62), a cautious technical signal.
- Over the past three years, CHRW has outperformed the S&P 500 by +6.48%, with a relative strength index reading of 104.2.
- Win rate over the trailing 39 months stands at 61.5% — 24 positive months versus 15 negative months.
C.H. Robinson ended September 2026 at $152.42, posting a monthly return of +1.84%. The S&P 500 returned −1.20% over the same window, leaving relative performance at +3.05%.
The current quarter stands at −19.07% (Q3 2026 (QTD)), while medium-term trend remains soft: price is −11.70% versus the 200-day moving average ($172.62).
Year-to-date, CHRW is −5.19% against SPY +11.13%, a gap of −16.32%. The stock is currently −27.53% below its 52-week high, with maximum 3-year drawdown at −32.37%.
| Period | CHRW | S&P 500 (SPY) | Excess return |
|---|---|---|---|
| 1 Day | +1.31% | −0.60% | +1.91% |
| 1 Week | +1.84% | −0.52% | +2.36% |
| 1 Month | +1.84% | −1.20% | +3.05% |
| 3 Months | −15.67% | +2.82% | −18.49% |
| 6 Months | −21.16% | +12.71% | −33.87% |
| YTD | −5.19% | +11.13% | −16.32% |
| 12 Months | +19.41% | +16.19% | +3.22% |
| 3 Years | +76.58% | +70.10% | +6.48% |
| Rank | Month | Return |
|---|---|---|
| #1 | May 2024 | +21.65% |
| #2 | Jan 2026 | +21.27% |
| #3 | Jul 2025 | +20.19% |
| #4 | Oct 2025 | +16.31% |
| #5 | Aug 2024 | +16.24% |
| Rank | Month | Return |
|---|---|---|
| #1 | Jul 2026 | −21.56% |
| #2 | Apr 2025 | −12.87% |
| #3 | Feb 2024 | −11.90% |
| #4 | Mar 2026 | −10.35% |
| #5 | Aug 2023 | −9.73% |
| Quarter | Return |
|---|---|
| Q2 2025 | −6.30% |
| Q3 2025 | +37.99% |
| Q4 2025 | +21.42% |
| Q1 2026 | +3.30% |
| Q2 2026 | +13.41% |
| Q3 2026 (QTD) | −19.07% |
| Year | Return |
|---|---|
| 2023 | −5.65% |
| 2024 | +19.60% |
| 2025 | +55.59% |
| 2026 | −5.19% |
| Metric | Value |
|---|---|
| 52-Week High | $210.33 (2026-07-22) |
| 52-Week Low | $123.64 (2025-10-14) |
| Current Price | $152.42 |
| 200-Day Moving Average | $172.62 |
| Price vs 200DMA | −11.70% |
| 3-Year Maximum Drawdown | −32.37% (2026-08-21) |
| Current Drawdown from 52W High | −27.53% |
| RS metric | Value |
|---|---|
| RS Index (3-year, rebased to 100) | 104.2 |
| 3-Year Excess Return vs S&P 500 | +6.48% |
| RS Peak | 151 (Feb 2026) |
| RS Trough | 69.9 (Apr 2024) |
| Status | Outperforming Benchmark |
Frequently asked questions
What was CHRW's return for this report period?
CHRW returned +1.84% in the latest monthly window ending 2026-09-10.
Has CHRW outperformed SPY year to date?
YTD CHRW: −5.19% vs SPY: +11.13%.
What is CHRW's 12-month return?
+19.41% over the trailing 12 months.
Is CHRW above or below its 200-day moving average?
Price is −11.70% versus 200DMA ($172.62).
What is the maximum drawdown in the 3-year window?
−32.37% on 2026-08-21.